4.5 Article Proceedings Paper

Robotic versus laparoscopic resection of liver tumours

Journal

HPB
Volume 12, Issue 8, Pages 583-586

Publisher

ELSEVIER SCI LTD
DOI: 10.1111/j.1477-2574.2010.00234.x

Keywords

laparoscopic surgery; liver; resection; robotic

Ask authors/readers for more resources

Background: There are scant data in the literature regarding the role of robotic liver surgery. The aim of the present study was to develop techniques for robotic liver tumour resection and to draw a comparison with laparoscopic resection. Methods: Over a 1-year period, nine patients underwent robotic resection of peripherally located malignant lesions measuring < 5 cm. These patients were compared prospectively with 23 patients who underwent laparoscopic resection of similar tumours at the same institution. Statistical analyses were performed using Student's t-test, chi(2)-test and Kaplan-Meier survival. All data are expressed as mean +/- SEM. Results: The groups were similar with regards to age, gender and tumour type (P = NS). Tumour size was similar in both groups (robotic -3.2 +/- 1.3 cm vs. laparoscopic -2.9 +/- 1.3 cm, P = 0.6). Skin-to-skin operative time was 259 +/- 28 min in the robotic vs. 234 +/- 17 min in the laparoscopic group (P = 0.4). There was no difference between the two groups regarding estimated blood loss (EBL) and resection margin status. Conversion to an open operation was only necessary in one patient in the robotic group. Complications were observed in one patient in the robotic and four patients in the laparoscopic groups. The patients were followed up for a mean of 14 months and disease-free survival (DFS) was equivalent in both groups (P = 0.6). Conclusion: The results of this initial study suggest that, for selected liver lesions, a robotic approach provides similar peri-operative outcomes compared with laparoscopic liver resection (LLR).

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Immunology

Induction Therapy With Antithymocyte Globulin and Delayed Calcineurin Inhibitor Initiation for Renal Protection in Liver Transplantation: A Multicenter Randomized Controlled Phase II-B Trial

Amit Nair, Laia Coromina Hernandez, Shimul Shah, Xaralambos Zervos, Michael Zimmerman, Kazunari Sasaki, Teresa Diago, Koji Hashimoto, Masato Fujiki, Federico Aucejo, Jessica Bollinger, Tiffany L. Kaiser, Charles M. Miller, Cristiano Quintini, John J. Fung, Bijan Eghtesad

Summary: In liver transplantation, delaying the initiation of calcineurin inhibitors (CNI) and using induction rabbit antithymocyte globulin (rATG) may help preserve early kidney function, especially when CNI initiation is delayed beyond 10 days or target tacrolimus levels are lower.

TRANSPLANTATION (2022)

Article Surgery

Combined heart-liver-kidney transplant: The university of Chicago medicine experience

Angelica Perez-Gutierrez, Umar Siddiqi, Gene Kim, Govind Rangrass, Aalok Kacha, Valluvan Jeevanandam, Yolanda Becker, Lisa Potter, John Fung, Talia B. Baker

Summary: This paper presents the best practices for successful execution of combined heart-liver-kidney transplantation, including patient selection, perioperative planning, and coordination among transplant teams. By careful selection and collaboration, this highly challenging operation can be successfully performed.

CLINICAL TRANSPLANTATION (2022)

Editorial Material Gastroenterology & Hepatology

The Sky Is Not Falling

John J. Fung

LIVER TRANSPLANTATION (2022)

Article Immunology

Nonhepatic Cancer in the Pediatric Liver Transplant Population: Guidelines From the ILTS-SETH Consensus Conference

Mohamed Rela, Jesus Quintero, Mureo Kasahara, Paolo Muiesan, Francisco Hernandez-Oliveros, Rajesh Rajalingam, Sadhana Shankar, Blayne Amir Sayed, Diego di Sabato, Ashwin Rammohan, John Fung, Itxarone Bilbao

Summary: The incidence and distribution of cancers in children are different from adults. Nonhepatic cancers should be considered in pediatric liver transplantation. With longer post-transplant survival and increased risk of new cancers, guidelines and best practices are needed for nonhepatic cancers in pediatric liver transplantation.

TRANSPLANTATION (2022)

Article Chemistry, Multidisciplinary

A Multifunctional Neutralizing Antibody-Conjugated Nanoparticle Inhibits and Inactivates SARS-CoV-2

Xiaolei Cai, Min Chen, Aleksander Prominski, Yiliang Lin, Nicholas Ankenbruck, Jillian Rosenberg, Mindy Nguyen, Jiuyun Shi, Anastasia Tomatsidou, Glenn Randall, Dominique Missiakas, John Fung, Eugene B. Chang, Pablo Penaloza-MacMaster, Bozhi Tian, Jun Huang

Summary: The study introduces a multifunctional nanoparticle that can capture and inactivate SARS-CoV-2 virus, efficiently blocking viral infection to host cells through surface neutralizing antibodies in vitro. Additionally, the nanoparticle has photothermal function to generate heat for virus inactivation. It significantly outperforms neutralizing antibodies in treating authentic SARS-CoV-2 infection in vivo and provides a flexible platform for potential broad protection against SARS-CoV-2 and its variants.

ADVANCED SCIENCE (2022)

Article Endocrinology & Metabolism

Islets Transplantation at a Crossroads-Need for Urgent Regulatory Update in the United States: Perspective Presented During the Scientific Sessions 2021 at the American Diabetes Association Congress

Piotr Witkowski, Louis H. Philipson, John B. Buse, R. Paul Robertson, Rodolfo Alejandro, Melena D. Bellin, Fouad Kandeel, David Baidal, Jason L. Gaglia, Andrew M. Posselt, Roi Anteby, Piotr J. Bachul, Yaser Al-Salmay, Kumar Jayant, Angelica Perez-Gutierrez, Rolf N. Barth, John J. Fung, Camillo Ricordi

Summary: In many countries, clinical islet allotransplantation has been successfully regulated as tissue/organ for transplantation and is considered safe and effective for selected patients with type 1 diabetes mellitus. However, in the United States, the FDA views pancreatic islets as a biologic drug, which has prevented islet transplantation from moving into the clinical arena. We propose including islets into the existing regulatory framework for organ transplantation, while maintaining FDA oversight, to ensure quality and efficacy.

FRONTIERS IN ENDOCRINOLOGY (2022)

Editorial Material Gastroenterology & Hepatology

Perspective: Advances in liver transplantation for hepatocellular carcinoma-A prototype for transplant oncology

John Fung, Diego DiSabato, Chih-Yi Liao, Osmanuddin Ahmed, Anjana Pillai

HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL (2023)

Article Oncology

Phase 1 Randomized Trial of Stereotactic Body Radiation Therapy Followed by Nivolumab plus Ipilimumab or Nivolumab Alone in Advanced/Unresectable Hepatocellular Carcinoma

Aditya Juloori, Rohan R. Katipally, Jeffrey M. Lemons, Anurag K. Singh, Renuka Iyer, Jared R. Robbins, Ben George, William A. Hall, Sean P. Pitroda, Fauzia Arif, John Fung, Anjana Pillai, Chih-Yi Liao, Manish Sharma, Stanley L. Liauw

Summary: This study investigated the safety and efficacy of stereotactic body radiation therapy (SBRT) with immunotherapy in patients with hepatocellular carcinoma (HCC). The results showed that the combination of SBRT with nivolumab plus ipilimumab had better survival and efficacy compared to immunotherapy alone in HCC patients, suggesting the need for further investigation.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2023)

Article Radiology, Nuclear Medicine & Medical Imaging

Yttrium-90 Radioembolization and Concomitant Systemic Gemcitabine, Cisplatin, and Capecitabine as the First-Line Therapy for Locally Advanced Intrahepatic Cholangiocarcinoma

Osman Ahmed, Qian Yu, Mikin Patel, Gloria Hwang, Anjana Pillai, Chih-yi Liao, John Fung, Talia Baker

Summary: A combination therapy of yttrium-90 transarterial radioembolization (TARE) and systemic gemcitabine, cisplatin, and capecitabine is safe and effective for the first-line treatment of locally advanced intrahepatic cholangiocarcinoma (iCCA), resulting in high rates of downstaging and favorable overall survival.

JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2023)

Review Medicine, General & Internal

Comparing High- and Low-Model for End-Stage Liver Disease Living-Donor Liver Transplantation to Determine Clinical Efficacy: A Systematic Review and Meta-Analysis (CHALICE Study)

Kumar Jayant, Thomas G. Cotter, Isabella Reccia, Francesco Virdis, Mauro Podda, Nikolaos Machairas, Ramesh P. Arasaradnam, Diego Di Sabato, John C. LaMattina, Rolf N. Barth, Piotr Witkowski, John J. Fung

Summary: This study compared the outcomes of high-MELD and low-MELD living-donor liver transplant recipients and found no significant differences in patient survival, graft survival, and most complications between the two groups. However, the high-MELD group had a higher risk of pulmonary infection, abdominal fluid collection, and prolonged ICU stay.

JOURNAL OF CLINICAL MEDICINE (2023)

Meeting Abstract Immunology

Safety and Effectiveness of COVID-19 Vaccination in the Islet Transplant Recipients

Mateusz Ogledzinski, Piotr J. Bachul, Braden Juengel, Yaser Al-Salmay, Jayant Kumar, Angelica Perez-Gutierrez, Lindsay Basto, Laurencia Perea, Ling-Jia Wang, Martin Tibudan, Rolf Barth, John Fung, Piotr Witkowski

TRANSPLANTATION (2022)

Meeting Abstract Immunology

A Positive B2 Microglobulin Trend Immediately After Transplant Identify Worse Outcomes in Patients With Delayed Graft Function

Angelica Perez-Gutierrez, Braden Juengel, Piotr J. Bachul, Yaser AlSalmay, Piotr Witkowski, John Fung, Yolanda T. Becker, Rolf N. Barth

TRANSPLANTATION (2022)

Meeting Abstract Immunology

Bacterial and Viral Infections After Kidney Transplant Before and After the COVID-19 Pandemic

Angelica Perez-Gutierrez, Braden Juengel, Sambhavi Krishnamoorthy, Piotr J. Bachul, Piotr Witkowski, Rolf N. Barth, John Fung

TRANSPLANTATION (2022)

Meeting Abstract Immunology

Extracorporeal Membrane Oxygenation Use in Orthotopic Liver Transplantation as a Viable Bridge to Transplant and Tool For Intraoperative and Postoperative Rescue

Govind Rangrass, Angelica Perez-Gutierrez, Dinesh J. Kurian, Aalok K. Kacha, Kymberly Harrington, John Fung

TRANSPLANTATION (2022)

Meeting Abstract Immunology

Successful Islet After Pancreas and Pancreas After Islet Transplantation for Patients With Diabetes Mellitus and Problematic Hypoglycemia

Piotr J. Bachul, Mateusz Ogledzinski, Braden Juengel, Yaser Al-Salmay, Jayant Kumar, Angelica Perez-Gutierrez, Lindsay Basto, Laurencia Perea, Ling-Jia Wang, Martin Tibudan, Rolf Barth, John Fung, Piotr Witkowski

TRANSPLANTATION (2022)

No Data Available